Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

People with early onset baldness (AGA) have higher blood sugar levels and lower sex hormone-binding globulin (SHBG) levels, suggesting SHBG could predict high blood sugar in these individuals.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young women with PCOS without additional risk factors may have normal heart function.

Young women with PCOS and no other heart risk factors have normal heart function.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

The method shows hair testosterone levels reflect those in saliva, but are affected by various factors and may indicate a risk for heart attack.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Young adults with hair loss face higher risk of stiff arteries.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

Men with early-onset hair loss have a higher risk of metabolic syndrome.

Early balding linked to higher heart disease risk.